A detailed history of Fmr LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Fmr LLC holds 11,523,128 shares of CYTK stock, worth $597 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,523,128
Previous 10,901,143 5.71%
Holding current value
$597 Million
Previous $764 Million 18.31%
% of portfolio
0.04%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$47.86 - $75.05 $29.8 Million - $46.7 Million
621,985 Added 5.71%
11,523,128 $624 Million
Q1 2024

May 13, 2024

SELL
$63.75 - $108.06 $134 Million - $228 Million
-2,106,640 Reduced 16.2%
10,901,143 $764 Million
Q4 2023

Feb 13, 2024

BUY
$26.88 - $83.49 $27.3 Million - $84.9 Million
1,016,959 Added 8.48%
13,007,783 $1.09 Billion
Q3 2023

Nov 13, 2023

SELL
$29.46 - $36.61 $5.07 Million - $6.3 Million
-172,144 Reduced 1.42%
11,990,824 $353 Million
Q2 2023

Aug 11, 2023

SELL
$32.62 - $40.75 $22.9 Million - $28.6 Million
-701,844 Reduced 5.46%
12,162,968 $397 Million
Q1 2023

May 11, 2023

SELL
$33.36 - $45.71 $16.5 Million - $22.6 Million
-495,146 Reduced 3.71%
12,864,812 $453 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $16.9 Million - $24.1 Million
471,287 Added 3.66%
13,359,958 $612 Million
Q3 2022

Nov 10, 2022

BUY
$38.54 - $54.52 $3.27 Million - $4.62 Million
84,810 Added 0.66%
12,888,671 $624 Million
Q2 2022

Aug 12, 2022

BUY
$33.93 - $48.92 $3.31 Million - $4.77 Million
97,495 Added 0.77%
12,803,861 $503 Million
Q1 2022

May 13, 2022

BUY
$29.74 - $46.0 $4.93 Million - $7.63 Million
165,817 Added 1.32%
12,706,366 $468 Million
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $1.91 Million - $2.58 Million
55,542 Added 0.44%
12,540,549 $572 Million
Q3 2021

Nov 15, 2021

BUY
$18.54 - $35.74 $74.1 Million - $143 Million
3,996,325 Added 47.08%
12,485,007 $446 Million
Q2 2021

Aug 13, 2021

BUY
$19.79 - $26.99 $168 Million - $229 Million
8,488,682 New
8,488,682 $168 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.88B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.